Summit Therapeutics Overview
Summit Therapeutics Discounted Cash Flow
DCF Analysis for SMMT.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.27
Current Fair Value
$0.27
↓ 98.0% Downside
Overvalued by 98.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison